Plainsboro, NJ, United States of America

Yingjun Fan

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Yingjun Fan: Innovator in Oral Drug Formulations**

Introduction

Yingjun Fan, based in Plainsboro, NJ, is an accomplished inventor known for his significant contributions to the field of pharmaceutical formulations. With a focus on enhancing drug delivery systems, he aims to improve treatment options for patients facing various health conditions.

Latest Patents

Yingjun Fan holds a patent for "Desmopressin Oral Compositions". This patent includes innovative formulations of desmopressin in oral liquid form, specifically designed to treat medical conditions such as diabetes insipidus, enuresis, hemophilia A, von Willebrand disease, and high blood urea levels. His work represents a substantial advancement in the accessibility and effectiveness of this important medication.

Career Highlights

Currently, Yingjun Fan is associated with Tulex Pharmaceuticals Inc., a company dedicated to developing novel therapeutic solutions. His expertise in pharmaceutical sciences has enabled him to be at the forefront of drug formulation technology, furthering the capabilities of medications designed for diverse medical applications.

Collaborations

Throughout his career, Yingjun has collaborated with talented professionals such as Yu-Hsing Tu and Kalyan Kathala. These partnerships highlight the importance of teamwork in the innovation process, allowing for the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical industry.

Conclusion

Yingjun Fan's contributions to the field of oral drug compositions underscore his role as a key inventor in modern medicine. His patent on desmopressin oral formulations showcases his commitment to improving patient outcomes, making him a noteworthy figure in the landscape of pharmaceutical innovations. His work at Tulex Pharmaceuticals Inc. continues to pave the way for advancements that benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…